Venture Life Group (LON:VLG) Stock Price Crosses Above 50 Day Moving Average – What’s Next?

Shares of Venture Life Group plc (LON:VLG) passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of GBX 67.35 and traded as high as GBX 70. Venture Life Group shares last traded at GBX 68.52, with a volume of 165,300 shares trading hands.

Venture Life Group Price Performance

The stock has a market cap of £79.95 million, a price-to-earnings ratio of 15.42, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.48 and a current ratio of 4.71. The business’s fifty day simple moving average is GBX 67.34 and its 200 day simple moving average is GBX 65.25.

Venture Life Group (LON:VLG) last issued its quarterly earnings data on Tuesday, September 29th. The company reported GBX 4.10 earnings per share for the quarter. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%. Research analysts predict that Venture Life Group plc will post 6.14 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Daniel Wells acquired 38,717 shares of the stock in a transaction that occurred on Wednesday, September 30th. The stock was purchased at an average cost of GBX 65 per share, with a total value of £25,166.05. Company insiders own 7.65% of the company’s stock.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.